DOA
TEVA icon

D'Orazio & Associates’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

D'Orazio & Associates’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,989
Closed -$220K – 270
2024
Q4 		$220K Sell
9,989
-1,034
-9% -$18.8K 0.03% 205
2024
Q3 		$199K Buy
+11,023
New +$193K 0.03% 228
2020
Q1 		– Sell
-18
Closed – – 360
2019
Q4 		$0 Hold
18
– – ﹤0.01% 359
2019
Q3 		$0 Sell
18
-320
-95% -$2.45K ﹤0.01% 377
2019
Q2 		$3K Hold
338
– – ﹤0.01% 297
2019
Q1 		$5K Hold
338
– – ﹤0.01% 280
2018
Q4 		$5K Hold
338
– – ﹤0.01% 248
2018
Q3 		$7K Hold
338
– – ﹤0.01% 228
2018
Q2 		$8K Hold
338
– – ﹤0.01% 213
2018
Q1 		$6K Hold
338
– – ﹤0.01% 230
2017
Q4 		$6K Sell
338
-201
-37% -$3.02K ﹤0.01% 258
2017
Q3 		$9K Hold
539
– – ﹤0.01% 203
2017
Q2 		$18K Buy
539
+201
+59% +$6.22K 0.01% 193
2017
Q1 		$11K Hold
338
– – ﹤0.01% 216
2016
Q4 		$12K Hold
338
– – ﹤0.01% 191
2016
Q3 		$15K Hold
338
– – 0.01% 180
2016
Q2 		$17K Hold
338
– – 0.01% 183
2016
Q1 		$18K Hold
338
– – 0.01% 182
2015
Q4 		$22K Hold
338
– – 0.01% 146
2015
Q3 		$20K Hold
338
– – 0.01% 147
2015
Q2 		$20K Hold
338
– – 0.01% 144
2015
Q1 		$21K Hold
338
– – 0.02% 149
2014
Q4 		$19K Hold
338
– – 0.01% 142
2014
Q3 		$18K Hold
338
– – 0.01% 145
2014
Q2 		$18K Hold
338
– – 0.01% 147
2014
Q1 		$18K Hold
338
– – 0.01% 141
2013
Q4 		$14K Buy
+338
New +$13.3K 0.01% 148

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

D'Orazio & Associates's TEVA Position: Q1 2025 in Review

D'Orazio & Associates sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2025, closing a stake of 9,989 shares — an estimated $220K sold.

D'Orazio & Associates first reported a position in TEVA in Q4 2013 and held it in 27 quarters. The position peaked at $220K in Q4 2024. 562 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

  • D'Orazio & Associates reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2025 after selling out during the quarter.
  • D'Orazio & Associates sold 9,989 Teva Pharmaceutical Industries Limited shares in Q1 2025, an estimated $220K.
  • D'Orazio & Associates first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 27 quarters.
  • D'Orazio & Associates's Teva Pharmaceutical Industries Limited position peaked at $220K in Q4 2024.
  • 562 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2025.

Based on D'Orazio & Associates's 13F filing for Q1 2025, filed 17 Apr 2025.